Identification and Characterization of a Protein Destruction Signal in the Encephalomyocarditis Virus 3C Protease*

T. Glen LawsonDagger , Donna L. Gronros, Paul E. Evans, Michelle C. Bastien, Katherine M. Michalewich, Justin K. Clark, Jay H. Edmonds, Karolina H. Graber, Jonathan A. Werner, Beth A. Lurvey, and Julie M. Cate

From the Department of Chemistry, Bates College, Lewiston, Maine 04240

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The amino acid sequence LLVRGRTLVV, which is probably located in a strand-turn-strand structure, has been identified as a protein destruction signal in the rapidly degraded encephalomyocarditis virus 3C protease. Mutations within this sequence reduced the susceptibility of the 3C protease toward ubiquitination and degradation in rabbit reticulocyte lysate. This signal is transferable, since poliovirus 3C protease, which is a poor ubiquitin-mediated proteolytic system substrate, was found to be ubiquitinated and degraded when the signal sequence was either generated at an internal location in the protein or fused to the N terminus. An evaluation of the behavior of 3C protease proteins containing mutations in the signal region indicates that considerable variability in the primary structure is tolerated, although the conservation of certain features appears to be required for signal function. Two E3 ubiquitin-protein ligases that recognize the encephalomyocarditis virus 3C protease as a substrate were also partially purified. One of these was identified as the previously described E3alpha , and this was shown to require the destruction signal sequence to catalyze efficiently the ubiquitination of the 3C protease. The other is a Ubc5-dependent E3 that appears to recognize a different, unidentified feature of the 3C protease.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Evidence accumulated to date has shown that proteins degraded by the ubiquitin (Ub)1-mediated proteolytic system (1, 2) contain structural features that serve as recognition signals for Ub system factors. These signals generally appear to be composed of short primary structure elements. A conserved nine-amino acid sequence, for example, in the A and B cyclins (3, 4), as well as in certain other proteins (5, 6), is required for these molecules to be recognized as substrates for Ub attachment and for degradation. Short regions rich in proline, glutamate, serine, and threonine, or PEST sequences, have been postulated to serve as protein degradation signals (7), and it now appears that some proteins containing these regions are substrates for the Ub-mediated proteolytic system (8-14). Proteins with certain N-terminal amino acids are subject to Ub-mediated proteolysis (15-18). Still other degradation signals have been demonstrated to exist, and in some cases their locations have been at least partially mapped (19-25). Given the small number of destruction signal elements whose locations have been precisely determined, it is difficult to conclude whether it is only the primary structures of these signals that are important for their recognition or whether defined, higher order structural features come into play. The destruction signal of the MATalpha 2 repressor, for example, has been hypothesized to contain an amphipathic alpha -helix (24).

Very few of the protein destruction signals that have been mapped so far have been shown to be recognized by a particular Ub system factor or factors. It is likely that the recognition of substrate proteins occurs primarily through the binding of a Ub-protein ligase, or E3, to the destruction signal elements (2). Several E3 proteins or protein complexes have been identified to date. As characterized by function, these can be divided into two classes (26). Some, such as SCF complexes composed of SKP1, CDC53, and an F-box protein (27), appear to operate as docking proteins by binding to both the substrate to be ubiquitinated and an E2 Ub-conjugating protein, the latter of which transfers the Ub molecule to the target. Other E3 proteins actually catalyze the attachment of Ub to the target, with a ubiquitinated E2 serving as a Ub donor. These include the mammalian E3alpha and its yeast homologue Ubr1 (28-31) and the family of hect Ub-protein ligases (32). E3alpha and Ubr1 are known to ubiquitinate N-end rule substrates (29, 30), and Ubr1 has recently been found to participate in the ubiquitination of the yeast proteins Galpha and Cup9 (18, 23), neither of which contains a destabilizing N-terminal amino acid. In the case of Galpha , the Ubr1 recognition element has been mapped to a 60-amino acid region near the N terminus (25), and the recognition of Cup9 requires the C-terminal two-thirds of the protein (23). The only other definitively known connection between a protein destruction signal and a Ub-protein ligase is that between the cyclin destruction signal sequence and the cyclosome complex (33, 34).

We have recently identified the 3C proteases of two picornaviruses as substrates for Ub-mediated degradation (35, 36). The 3C proteases are cysteine proteases of approximately 21-24 kDa which exhibit a high degree of substrate specificity (37). These proteins are initially synthesized within large polyproteins encoded by the positive stranded RNA viral genomes. They are responsible for most of the proteolytic processing of the polyproteins, which leads to the generation of individual functional proteins, including free, mature 3C proteases (37, 38). The mature 3C protease of the encephalomyocarditis virus (EMCV) has been shown to be rapidly degraded in vivo and in vitro (39, 40). Indirect evidence indicates that the mature 3C protease of the hepatitis A virus (HAV) is short lived in vivo (41), and it has been directly proven to be quickly degraded in rabbit reticulocyte lysate (36). The destruction of both of these proteins requires both the synthesis of Ub-3C protease conjugates and the action of the proteasome (35, 36). Neither of these 3C proteases possesses a destabilizing N-terminal amino acid or homology with any reported sequences suspected of being required for recognition by the Ub-mediated proteolytic system.

In order to understand how the short lived 3C proteases are selected for rapid destruction and to facilitate studies of what role this destruction might play in the viral infectious cycles, we have attempted to identify structural features of the EMCV 3C protease that are required for recognition by the Ub-mediated proteolytic system. Because we have recently demonstrated that at least one Ub-conjugating system component in rabbit reticulocyte lysate recognizes both the EMCV and the HAV 3C proteases (36), and because of the difficulties associated with detecting unstable 3C proteases in vivo, we have employed the reticulocyte lysate system in our search. Here we report the identification and characterization of a 10-amino acid destruction signal sequence in the EMCV 3C protease. An analogous sequence is demonstrated to exist in the HAV 3C protease as well. In addition, we have identified two E3 Ub-protein ligases, one being E3alpha , that recognize the EMCV 3C protease and consequently catalyze the conjugation of Ub to the protein.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Construction of in Vitro Transcription Plasmids Containing 3C Protease Wild Type, Mutated, and Fusion Coding Sequences-- pE3C (36) or pE3B'CD'* (35) were employed in the construction of all in vitro transcription plasmids containing mutated EMCV 3C protease coding sequences. pETP3C (36) or pT7-1 (42) were used as the starting points for the construction of all plasmids containing mutated poliovirus 3C protease coding sequences. pE5P-P3 (43) was used as the source of sequences to construct transcription vectors encoding mutated HAV 3C protease coding sequences. All insert DNA fragments were prepared by PCR using PfuI DNA polymerase (Stratagene). All synthetic primers were obtained from Biosynthesis. Site-specific mutagenesis was accomplished using both coding and non-coding strand mutagenic primers. The large number of synthetic primers utilized in this study precludes listing the sequences here, and these may be obtained from the authors upon request. The 3C protease coding regions of all DNA constructs were sequenced with an Applied Biosystems automated DNA sequencer.

The inserts for pENPC and pPNEC, plasmids carrying the coding sequences for fused N- and C-terminal halves of the EMCV 3C and poliovirus 3C proteases, were prepared by two rounds of PCR. In the first round, the N- and C-terminal coding halves of each sequence were amplified from pE3C and pETP3C using primers containing the common 5' ... TTCAGAGAC ... 3' (FRD encoding) region and flanking primers containing the appropriate restriction endonuclease sites. In the second round, the sequences were fused in frame via the common aforementioned sequence, using the appropriate flanking primers. The NcoI- and EcoRI-treated insert for pENPC was inserted into modified pGEM-3Z (35), and the NcoI- and BamHI-treated insert for pPNEC was inserted into pET3d (44). Inserts for pE3C(N), pE3C(C), pE3C-5, pE3C-15, pE3C-26, and pE3C-46 were prepared by amplifying the sequence to be retained with NcoI-containing coding strand deletion primers and EcoRI-containing non-coding strand flanking primers. Restriction endonuclease-treated inserts were ligated into modified pGEM-3Z. For constructs carrying codon mutations in the suspected EMCV 3C protease destruction signal sequence region or for constructs carrying EMCV 3C protease coding sequences with one or two lysine to arginine codon changes, the appropriate mutagenic primers and flanking primers containing NcoI and EcoRI sites were employed to amplify sequences from pE3C or pE3B'CD'*. Plasmids containing additional lysine to arginine codon changes in the EMCV 3C coding sequence (pE3CK(1-5)R, pE3CK(8-12)R, pE3CK(6-12)R, and pE3CK(1-12)R) were prepared from multiple rounds of PCR with mutagenic and flanking primers. The restriction endonuclease-treated inserts were ligated into modified pGEM-3Z.

The insert for pETP3C-DS, which carries the sequence coding for the poliovirus 3C-DS protein, was prepared by two rounds of PCR amplification of the poliovirus 3C encoding DNA carried in pT7-1. Mutagenic primers and flanking primers containing NcoI or BamHI sites were employed. The NcoI- and BamHI-treated fragment was ligated into pET3d. pP3C-NDS, which carries the poliovirus 3C protease wild type coding sequence fused with a sequence encoding the N-terminal addition MGLLVRGRTLVV, was prepared as follows. A 75-base coding strand primer containing an NcoI site, the sequence coding for MGLLVRGRTLVV, and a sequence that overlaps the N-terminal encoding wild type sequence was used in combination with a non-coding strand flanking primer containing an EcoRI site to amplify the poliovirus 3C encoding sequence from pT7-1. Following treatment with NcoI and EcoRI, the resulting DNA fragment was ligated into modified pGEM-3Z. A modified version of this plasmid, pP3C-NDSI, was generated by using the mutagenic primers and PCR to synthesize a DNA insert in which the codons for the LVV sequence in the N-terminal extension were changed to codons for AAA. This insert was also ligated into modified pGEM-3Z. For the construction of pP3CA35L and pP3CA35L,I36L, the appropriate mutagenic primers and flanking primers containing NcoI or EcoRI sites were employed to amplify sequences from pETP3C. The restriction endonuclease-treated inserts were ligated into modified pGEM-3Z.

For the construction of pHAV3CL32A,V34A and pHAV3CLLV(39-41)AAA, which carry the HAV 3C protease coding sequence with two or three codon mutations, respectively, the appropriate mutagenic primers and flanking primers containing NcoI or EcoRI sites were employed to amplify sequences from pE5P-P3. The restriction endonuclease-treated inserts were ligated into modified pGEM-3Z.

Cloning, Expression, and Purification of EMCV 3C Protease and Mutated Protease Proteins-- The preparation of Escherichia coli cells that express the wild type EMCV 3C protease has already been described (35). The mutated 3C coding sequence carried in pE3CLVV(41-43)AAA (see "Results") was amplified by PCR using primers containing NcoI or BamHI. The restriction endonuclease-treated fragment was ligated into pET-3d. This construct was used to transform E. coli BL21 (pLysS) cells. Expression, refolding, and purification of the protein were carried out as described previously (35).

Evaluation of the Susceptibility of the Mutated 3C Protease Proteins toward Conjugation with Ub and Degradation-- The in vitro transcriptions and translations in reticulocyte lysate were carried out as described previously (40). The ability of the 35S-labeled 3C protease proteins to be conjugated with MeUb (35, 45) was tested in reaction mixtures containing 20 mM HEPES-KOH, pH 7.5, 100 mM KC2H3O2, 1 mM Mg(C2H3O2)2, 1 mM DTT, 0.1 mM MeUb, and 0.1 mg/ml cycloheximide in 50% (v/v) nuclease-treated reticulocyte lysate containing an ATP-regenerating system (35). The reaction mixtures were incubated at 30 °C, and 1.5-µl aliquots were removed at the indicated times and analyzed by 12 or 16% SDS-PAGE and autoradiography as described previously (40).

The degradation of the 35S-labeled proteins in the reticulocyte lysate system was monitored in reaction mixtures similar to that described above, except MeUb was replaced with 0.1 mM bovine Ub (Sigma). In some reactions 0.1 µM Ub aldehyde (46), kindly provided by K. Wilkinson, was used in place of Ub. When lactacystin (Boston Biomedica) was included, it was added to give a final concentration of 100 nM. These reaction mixtures were incubated at 30 °C, and 1.5-µl aliquots were removed at the indicated times and analyzed by 12% SDS-PAGE and autoradiography. In some cases the amount of radioactivity present in the 35S-labeled 3C protease proteins was measured by liquid scintillation counting (40).

Evaluation of the Catalytic Activity of the Mutated EMCV 3C Protease Proteins-- The activity of the in vitro synthesized EMCV 3C protease proteins was tested using 35S-labeled EMCV LVP0 polyprotein as a substrate as described previously (40).

Protein Purifications and Reactions with E1, E2, and E3 Preparations-- Partially purified rabbit Ubc5 and purified rabbit E2-14K and E1 were kindly donated by C. Pickart. Human E3alpha , purified by affinity chromatography using an E2-14K column, was the generous gift of A. Haas.

UbcH5 was purified from expressing E. coli cells kindly provided by P. Howley (see Ref. 47). The UbcH5 purification procedure was adapted from procedures developed by L. Mastrandrea and C. Pickart.2 After induction with 0.08 mM isopropyl-beta -D-thiogalactopyranoside for 5 h at 30° C, 10 g of pelleted cells were recovered and lysed by freezing and thawing in 2 volumes of 50 mM Tris-HCl, pH 7.6, 10 mM MgCl2, 2 mM DTT, 1 mM p-toluenesulfonyl fluoride, 0.1 mM EDTA, 10 µg/ml leupeptin, and 10 µg/ml DNase I. Following removal of cell debris by centrifugation, the 50-80% (NH4)2SO4 precipitate fraction was recovered and dialyzed against 10 mM Tris-HCl, pH 7.6, 1 mM DTT, and 0.1 mM EDTA. The material was filtered through 20 ml of Q-Sepharose (Amersham Pharmacia Biotech) equilibrated with 50 mM Tris-HCl, 2 mM DTT, 0.1 mM EDTA, 0.1 mM p-toluenesulfonyl fluoride, and 2 µg/ml leupeptin. The flow-through was concentrated and loaded onto a 44 × 1-cm column of Sephadex S-200 (Amersham Pharmacia Biotech) equilibrated in 50 mM Tris-HCl, 2 mM DTT, and 0.1 mM EDTA. The 16-kDa UbcH5 eluted between about 25 and 30 ml. The UbcH5-containing fractions were stored in aliquots with 0.1 mg/ml added ovalbumin.

A 0-30% (NH4)2SO4 precipitated fraction of fraction II (DEAE-bound; Ref. 48) protein from rabbit reticulocyte lysate, generously provided by C. Pickart, was used as the starting material for the partial purification of E3 Ub-protein ligases that recognize the EMCV 3C protease. The Ubc5-dependent E3 activity was partially purified as follows. Eighty mg of 0-30% (NH4)2SO4 precipitated rabbit reticulocyte fraction II protein was loaded onto 4 ml of Q-Sepharose equilibrated with 50 mM Tris-HCl, pH 7.6, 1 mM DTT, and 0.1 mM EDTA (TDE buffer). Following washing with 24 ml of TDE buffer, bound protein was eluted with a 45-ml linear gradient of 0.1-0.5 M NaCl in TDE. Fractions containing the E3 activity peak (eluting between about 0.30 and 0.35 M NaCl) were pooled and concentrated. This material (17 mg of protein) was loaded onto an 80 × 1-cm column of Sephadex S-200 equilibrated with TDE buffer. The E3 activity eluted between 27 and 32 ml. These fractions were pooled, concentrated, and then dialyzed against 1.0 M (NH4)2SO4 in 20 mM sodium phosphate, pH 7.4, and 2 mM DTT (PD buffer), followed by dialysis against the same buffer containing 0.6 M (NH4)2SO4. The dialyzed material was loaded onto a column of 5 ml of methyl-HIC resin (Bio-Rad) equilibrated in PD buffer containing 0.6 M (NH4)2SO4. The column was washed with 2 volumes of the same buffer, and bound protein was eluted with a 25-ml linear gradient of 0.6-0.3 M (NH4)2SO4 in PD buffer. The fractions were desalted by multiple rounds of concentration and dilution in TDE buffer containing 0.1 mg/ml ovalbumin. The E3 activity eluted between 0.55 and 0.45 M (NH4)2SO4.

The typical reconstitution assay reaction mixtures consisted of 50 mM Tris-HCl, pH 7.6, 10 mM creatine phosphate, 5 mM MgCl2, 4 mM ATP, 0.6 units/ml creatine phosphokinase, 0.6 units/ml inorganic pyrophosphatase, either 1 or 9 µM EMCV 3C or 3C[LVV(41-43)AAA] proteases, 0.2 mM Ub or MeUb, 0.1 µM E1, approximately 1-2 µM UbcH5 or E2-14K, and up to 2 µg of E3-containing preparation, in a final volume of 8 or 12 µl. The mixtures were incubated at 37 °C. Two-µl aliquots were removed from the mixtures at the indicated times and were subjected to 12% SDS-PAGE. 3C protease and Ub-3C protease conjugates were detected by Western blotting, using affinity purified antibodies against EMCV 3C protease (35) as the primary antibody. Blot development was accomplished using secondary antibody-conjugated alkaline phosphatase (for 9 µM 3C protease reactions) or the enhanced chemiluminescence (ECL) detection system (Amersham Pharmacia Biotech; for 1 µM 3C protease reactions).

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Identification of a Signal Required for the Conjugation of Ub to the EMCV 3C Protease-- In order to determine whether the recognition of the EMCV 3C protease by the Ub-conjugating system occurs because of a discrete, identifiable structural feature within the substrate protein, several fusion and deletion mutants were prepared and evaluated. Portions of the EMCV 3C protease were first fused with portions of the poliovirus 3C protease, which is known to be a poor substrate for the Ub-mediated proteolytic system (36). Although the poliovirus protein does not share extensive sequence homology with the EMCV 3C protease (49, 50), the two do contain the centrally placed common sequence FRD, located at positions 92-94 in the EMCV 3C protease and at positions 83-85 in the poliovirus 3C protease. This shared sequence was utilized to construct in vitro transcription plasmids carrying either the sequence coding for the N-terminal half of the EMCV 3C protease fused with the C-terminal half of the poliovirus 3C protease (ENPC protein) or the sequence coding for the N-terminal half of the poliovirus 3C protease fused with the C-terminal half of the EMCV 3C protease (PNEC protein). The ability of proteins encoded by these plasmids (Fig. 1A) to become incorporated into conjugates in reticulocyte lysate in the presence of methylated Ub (MeUb) was evaluated. Although reticulocyte lysate contains endogenous Ub, which can become incorporated into polymeric Ub chains conjugated to substrate proteins, the inclusion of a high concentration of MeUb (45) in the reaction mixtures results in the synthesis of more easily detected and relatively stable mono-Ub conjugates, at least with full-length wild type 3C protease proteins (35, 36). The use of MeUb in this system facilitates the detection of even low levels of ubiquitination, and it allows comparisons to be easily made between the abilities of proteins to serve as substrates for the initial Ub conjugation event. As shown in Fig. 1B, only the ENPC protein serves as a substrate for Ub attachment, demonstrating that the N-terminal 94 amino acids of the EMCV 3C protease include at least some elements required for recognition by the Ub system. This was confirmed by testing the ability of the N- or the C-terminal regions of the EMCV 3C protease alone (Fig. 1A) to serve as substrates for ubiquitination. A polypeptide composed of amino acids 1-101 (E3C(N)) was found to be readily conjugated with at least four MeUb molecules, whereas a polypeptide composed of amino acids 102-205 (E3C(C)) was a poor substrate for conjugate formation (Fig. 1C). A further evaluation of the N-terminal portion of the EMCV 3C protease by deletion mutagenesis revealed that the elimination of the N-terminal 5, 15, or 26 amino acids from the wild type protein had little effect on ubiquitination (Fig. 1A). Elimination of the N-terminal 46 amino acids, however, completely abolished all Ub conjugate formation (Fig. 1D). This suggests that the Ub system recognizes a structural feature located within the region which includes amino acids 27-46.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 1.   Fusion proteins and deletion mutants employed to locate the destruction signal region in the EMCV 3C protease. A, diagrams of fusion proteins and deletion mutants employed and the results of incubating the in vitro synthesized proteins in the reticulocyte lysate system in the presence of MeUb. Open boxes indicate EMCV 3C protease (E3C) sequences, and hatched boxes indicate poliovirus 3C protease (P3C) sequences. The numbers indicate the amino acid positions in the EMCV or the poliovirus 3C proteases. The identities of the three amino acids located at each end of the proteins are shown. Methionine residues added to the N termini of the wild type sequences to allow translation initiation are indicated by M outside the boxes. B, autoradiograph of the SDS-PAGE analysis of aliquots removed from reaction mixtures containing the ENPC and PNEC fusion proteins. Lane 1, ENPC, 0 min; lane 2, ENPC, 60 min; lane 3, PNEC, 0 min; lane 4, PNEC, 60 min. C, autoradiograph of the SDS-PAGE analysis of aliquots removed from reaction mixtures containing the E3C(N) and E3C(C) proteins. Lane 1, E3C(N), 0 min; lane 2, E3C(N), 60 min; lane 3, E3C(C), 0 min; lane 4, E3C(C), 60 min. D, autoradiograph of the SDS-PAGE analysis of aliquots removed from reaction mixtures containing the non-mutated EMCV (E3C) and E3C-46 3C proteins. Lane 1, E3C, 0 min; lane 2, E3C, 60 min; lane 3, E3C-46, 0 min; lane 4, E3C-46, 60 min. * indicates the location of MeUb conjugates.

Although EMCV 3C protease shares little sequence homology with HAV 3C protease (50, 51), the fact that the two proteins are recognized by a common Ub-conjugating system component in rabbit reticulocyte lysate (36) led us to compare amino acid positions 27-46 in the EMCV 3C protease with the similar region in the HAV 3C protease. Fig. 2 shows the sequence of this region of the EMCV 3C protease, aligned with the analogous regions in the HAV and poliovirus 3C proteases (52). Based upon amino acid R group similarity and the location of the conserved catalytic histidine, the LLV sequence at positions 34-36 in the EMCV 3C protease can be aligned with the LGV sequence at positions 32-34 in the HAV 3C protease, and the LVV sequence at positions 41-43 in the EMCV 3C protease can be matched with the LLV sequence at positions 39-41 in the HAV 3C protease. The poliovirus 3C protease contains an LGV sequence (positions 28-30) in this region as well, but it contains an AIL sequence at positions 35-37, instead of either LVV or LLV. The crystal structures of the HAV, poliovirus, and rhinovirus 3C proteases have been determined (53-55), and all three have very similar secondary and tertiary structural arrangements. Amino acids 32-41 of the HAV protein and amino acids 28-37 of the poliovirus protein are contained within similarly folded structures in which the central four, primarily hydrophilic, amino acids comprise a surface-exposed loop that connects two antiparallel beta -sheet strands. There is no reason not to expect that the aligned EMCV 3C protease sequence also exists within a strand-turn-strand structure. Based upon these comparisons, we hypothesized that the 10-amino acid sequence LLVRGRTLVV in the EMCV 3C protease might comprise a protein destruction signal that is recognized by a Ub-mediated proteolytic system component. We also predicted that, if this is the case, then the LGVKDDWLLV segment in the HAV 3C protease could serve this function as well.


View larger version (12K):
[in this window]
[in a new window]
 
Fig. 2.   The amino acid sequence of the EMCV 3C protease from positions 27 to 46 and the aligned sequences from the HAV and poliovirus 3C proteases. The catalytic histidine common to all three proteins is shown in bold.

In order to test whether the LLVRGRTLVV sequence is involved in the recognition of the EMCV 3C protease for ubiquitination and degradation, the amino acids comprising the LLV and LVV triplets, at positions 34-36 and 41-43, respectively, were substituted with alanine residues. Whereas the incubation of in vitro synthesized non-mutated 3C protease in reticulocyte lysate in the presence of MeUb resulted in the synthesis of an easily detected mono-Ub conjugate, a much smaller fraction of the mutated proteins was incorporated into these conjugates during the incubations (Fig. 3A). In addition, the presence of endogenous Ub in the lysate resulted in the incorporation of a portion of the non-mutated 3C protease into poly-Ub conjugates during its synthesis. This is revealed by the ladder of bands, previously shown to represent Ub-3C protease conjugates (35), above the primary translation product in lane 1 (0-min sample) of Fig. 3A. These high molecular weight polymeric conjugates are difficult to detect in the newly synthesized mutated 3C protease samples (lanes 4 and 7). The mutated proteins were degraded considerably more slowly than the non-mutated protein (Fig. 3B), with the initial rates of destruction being about one-third that measured for the non-mutated 3C protease. The addition of Ub aldehyde to the reticulocyte lysate system, at a concentration known to inhibit isopeptidases (46), did not result in an increase in the rates at which the non-mutated or the mutated EMCV 3C proteases were degraded (data not shown). This indicates that the effects of the mutations are due to an inhibition of the conjugation of Ub to the 3C protease and not to an increased rate of Ub removal from Ub-3C protease conjugates. It appears, then, that the LLV and LVV triplets in the proposed signal sequence are indeed involved in the attachment of Ub to the EMCV 3C protease and are required for the rapid destruction of the protein.


View larger version (81K):
[in this window]
[in a new window]
 
Fig. 3.   Evaluation of the ability of the EMCV 3C[LLV(34-36)AAA] and 3C[LVV(41-43)AAA] proteins to serve as substrates for the reticulocyte Ub-mediated proteolytic system. A, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized non-mutated and mutated EMCV 3C protease proteins were incubated in the presence of MeUb. Lanes 1-3, non-mutated EMCV 3C protease; lanes 4-6, EMCV 3C[LLV(34-36)AAA] protease; lanes 7-9, EMCV 3C[LVV(41-43)AAA] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1, 4, and 7), 15 min (lanes 2, 5, and 8), and 60 min (lanes 3, 6, and 9). * indicates the location of mono-Ub conjugates. B, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized non-mutated and mutated EMCV 3C protease proteins were incubated in the presence of added Ub. Lanes 1-4, non-mutated EMCV 3C protease; lanes 5-8, EMCV 3C[LLV(34-36)AAA] protease; lanes 9-12, EMCV 3C[LVV(41-43)AAA] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1, 5, and 9), 30 min (lanes 2, 6, and 10), 90 min (lanes 3, 7, and 11), and 180 min (lanes 4, 8, and 12).

Further evidence that the LLVRGRTLVV region in the EMCV 3C protease functions as a destruction signal was obtained by mutating the poliovirus 3C protease sequence shown in Fig. 2. Alterations were made in this section of the sequence to increase its homology with the EMCV 3C protease sequence. A mutated poliovirus protein, designated 3C-DS (for destruction signal), containing the sequence LGVRDRTLVV in place of LGVHDNVAIL was prepared. This new sequence is identical to the putative EMCV 3C protease destruction signal, except that Gly-29 and Asp-32 were left unchanged. These residues also occur in the HAV 3C protease sequence (Fig. 2), so we predicted they would allow the signal sequence to function. The poliovirus 3C-DS protein was found to be subject to conjugation with MeUb (Fig. 4A, lanes 1-6). Analysis of the in vitro translation reactions in which the 3C-DS protein was synthesized revealed the presence of poly-Ub-conjugated protein products (Fig. 4A, lanes 7 and 8), which were almost absent in the non-mutated poliovirus 3C protease synthesis reactions. In addition, although the wild type poliovirus 3C protease was quite stable in the reticulocyte system, the mutated protein was degraded (Fig. 4B). The rate of this degradation was reduced by lactacystin (Fig. 4C; ref. 56), implicating the involvement of the proteasome.


View larger version (52K):
[in this window]
[in a new window]
 
Fig. 4.   Evaluation of the ability of the poliovirus 3C-DS, 3C-NDS, and 3C-NDSI proteins to serve as substrates for the reticulocyte Ub-mediated proteolytic system. A, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized poliovirus 3C and 3C-DS proteins were incubated in the presence of MeUb. Lanes 1-3, poliovirus 3C protease; lanes 4-6, poliovirus 3C-DS protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1 and 4), 15 min (lanes 2 and 5), and 60 min (lanes 3 and 6). Lanes 7 and 8 show the analysis of aliquots of in vitro translation reaction mixtures used to prepare the non-mutated 3C and 3C-DS proteins, respectively. The time for the autoradiography of these samples was extended to enhance visualization of poly-Ub conjugates. * indicates the location of mono-Ub conjugates. B, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized poliovirus 3C and 3C-DS proteins were incubated in the presence of added Ub. Lanes 1-4, poliovirus 3C protease; lanes 5-8, poliovirus 3C-DS protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1 and 5), 30 min (lanes 2 and 6), 90 min (lanes 3 and 7), and 180 min (lanes 4 and 8). C, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized poliovirus 3C-DS protein was incubated in the absence or presence of lactacystin and added Ub. Aliquots were removed from the reaction mixtures at 0 min (lanes 1), 10 min (lanes 2), 30 min (lanes 3), 60 min (lanes 4), and 120 min (lanes 5). D, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized poliovirus 3C-NDS and 3C-NDSI proteins were incubated in the presence of MeUb. Lanes 1 and 2 show a comparison of aliquots of in vitro translation reaction mixtures used to prepare non-mutated poliovirus 3C and 3C-NDS proteins, respectively. The time for the autoradiography of these samples was extended to enhance visualization of poly-Ub conjugates. Lanes 3-5, poliovirus 3C-NDS protein incubated with MeUb; lanes 6-8, poliovirus 3C-NDSI protein incubated with MeUb. Aliquots were removed from the reaction mixtures at 0 min (lanes 3 and 6), 15 min (lanes 4 and 7), and 60 min (lanes 5 and 8). * indicates the location of mono-Ub conjugates.

An important question is whether the proposed EMCV 3C protease destruction signal sequence can also function if it is located somewhere else in a substrate protein. In order to answer this, a DNA sequence coding for the EMCV 3C protease destruction signal was fused to the wild type poliovirus 3C protease coding sequence. This allowed for the synthesis of the poliovirus 3C protease with the sequence MGLLVRGRTLVV fused to the N-terminal proline residue of the poliovirus protein (designated the 3C-N-terminal destruction signal or 3C-NDS protein). The presence of the new N-terminal MG results from the construction of the transcription plasmid. The analysis of the in vitro translation product of the RNA coded for by this plasmid revealed the presence of high molecular weight labeled species, consistent with the formation of poly-Ub conjugates in the reticulocyte system (Fig. 4D, lanes 1 and 2). The incubation of the poliovirus 3C-NDS protein in the presence of MeUb resulted in the synthesis of a detectable mono-Ub-3C-NDS conjugate (Fig. 4D, lanes 3-5). The 3C-NDS protein was also degraded at a rate similar to that of the poliovirus 3C-DS protein shown in Fig. 4B, lanes 5-8. These results indicate that the fusion of the signal sequence to the N terminus of the poliovirus 3C protease leads to the recognition of the protein as a substrate for ubiquitination. In order to ascertain whether the effects of the N-terminally located destruction sequence are specifically due to the signal itself, and not simply the presence of the extra N-terminal amino acids, the signal sequence was mutated to MGLLVRGRTAAA (poliovirus 3C-NDSI). This is analogous to the EMCV 3C protease mutant with the LVV sequence at positions 41-43 replaced with AAA (Fig. 3). The poliovirus 3C-NDSI protein was incorporated into conjugates with MeUb less readily than was the 3C-NDS protein (Fig. 4D, lanes 6-8), indicating that the transfer of susceptibility toward conjugation with Ub results, at least primarily, from the attachment of the destruction signal sequence.

Additional Characterization of the Destruction Signal and the Location of Ub Attachment Sites-- An effort was made to systematically evaluate which features in the EMCV 3C protease destruction signal are important for recognition by the Ub system. Several mutations, the majority being single alanine substitutions, were generated in the destruction signal sequence. The mutated proteins that were synthesized, and the relative susceptibility of these proteins toward conjugation with Ub in the reticulocyte lysate system, are summarized in Table I. The effects of the mutations were determined by comparing the fractions of the proteins that were incorporated into mono-Ub conjugates during a 15-min incubation in the presence of MeUb, with the extent of ubiquitination observed with the non-mutated 3C protease. None of the mutated proteins demonstrated a greater susceptibility toward recognition by the Ub system than the non-mutated EMCV 3C protease. The relative rates at which these proteins were degraded correlated with their relative susceptibilities toward conjugation with MeUb. The results indicate few of the single amino acid changes strongly reduced the ability of the destruction signal sequence to function. One exception to this is the first amino acid in the sequence, Leu-34, which is conserved in the analogous positions in the HAV and poliovirus 3C proteases. The substitution of an alanine or methionine residue for this leucine, which would not be expected to induce drastic structural changes, strongly reduced the efficiency of Ub conjugation, as did the substitution of a valine. Whereas the replacement of the arginine at position 39 with an alanine or lysine residue negatively affected the efficiency of ubiquitination of the EMCV 3C protease, the presence of an aspartate in this position resulted in an even more poorly ubiquitinated substrate. This suggests that signal functionality is dependent upon more than simply the presence of polar amino acids in this region. In addition, the simultaneous replacement of both arginines in the central region of the signal with alanine residues virtually eliminated the susceptibility of the 3C protease toward conjugation with ubiquitin. Besides causing an obvious reduction in the hydrophilic character of this part of the signal sequence, these mutations may result in significant higher order structural alterations. The strongly inhibitory effects of eliminating a residue from (Delta Gly-38), or adding a residue to (+Ala-38), the sequence indicates that a number of residues in the sequence, or at least in the central region, may also be important. All of the mutated proteins listed in Table I, as well as the triple alanine substitutions described above (Fig. 3), were tested for catalytic activity. Except for the 3C[LLV(34-36)AAA] protein, all retained the ability to catalyze the cleavage of the leader (L) protein from the EMCV polyprotein capsid precursor LVP0 (40). For these mutated proteins, at least, the retention of catalytic activity is indicative of minimal alterations in the overall higher order structures.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Effects of single amino acid changes in the destruction signal sequence on the conjugation of Ub to the EMCV 3C protease.

The severe attenuation of the conjugation of Ub to the EMCV 3C[LLV(34-36)AAA]- and 3C[LVV(41-43)AAA] proteins (Fig. 3A) and the absence of leucines or valines in positions 35 and 36 of the wild type poliovirus 3C protease (Fig. 2) raise the possibility that a high density of leucine and valine residues in the three positions on both ends of the destruction signal sequence are necessary for the signal to function. Support for this hypothesis was obtained by testing the ability of poliovirus 3C protease proteins containing A35L or A35L plus I35L substitutions to serve as substrates for the Ub-mediated proteolytic system. Both the single and double leucine substitutions allowed the protein to become ubiquitinated and to be degraded at rates comparable to that observed for the poliovirus 3C-DS protein, shown in Fig. 4, A and B (data not shown).

Given that the EMCV 3C protease undergoes conjugation with Ub primarily at a single lysine (35), an attempt was made to determine if a specific lysine in the EMCV 3C protease, perhaps because of its location relative to that of the destruction signal, is exclusively utilized as the Ub attachment site. All 12 of the lysine residues in the 3C protease were replaced with arginine residues, either individually or in pairs. The extent to which all of these substitution mutants were incorporated into MeUb-3C protease conjugates in the reticulocyte lysate system was only slightly less than that observed for the non-mutated protein (data not shown). Additional mutagenesis was performed to prepare in vitro transcription vectors that code for the 3C protease with lysine to arginine substitutions at positions 10, 14, 68, 74, and 78 (3C[K(1-5)R] protease), positions 151, 156, 171, and 172 (3C[K(8-12)R] protease), positions 101, 130, 151, 156, 171, and 172 (3C[K(6-12)R] protease), and at all 12 lysine positions (3C[K(1-12)R] protease). The results of incubating these proteins in reticulocyte lysate in the presence of MeUb are shown in Fig. 5A. Only the 3C[K(1-12)R] protease protein was found to be completely resistant to ubiquitination, although the other mutated proteins were less susceptible to conjugation with MeUb than was the non-mutated 3C protease. A comparison of the stabilities of these proteins is shown in Fig. 5B. Whereas the 3C[K(1-5)R), 3C[K(8-12)R), and 3C[K(6-12)R] proteins were degraded less rapidly than was the non-mutated EMCV 3C protease, presumably a reflection of their reduced susceptibility toward ubiquitination, the 3C[K(1-12)R] protease was found to be degraded quite slowly. This no lysine version of the 3C protease was degraded at a rate about one-fourth that measured for the non-mutated protein, and this degradation was not inhibited by lactacystin (Fig. 5C). The ubiquitin and proteasome-independent destruction of the EMCV 3C protease is likely due to one or more other proteases present in the reticulocyte lysate. We have previously observed, for example, that other EMCV proteins, including the LVP0 polyprotein and the 3D polymerase are degraded in the reticulocyte system, although at rates that are considerably slower than that of the mature 3C protease (40). This turnover does not appear to require the ubiquitination of these proteins (35). All of the lysine to arginine mutants retained levels of catalytic activity comparable to that of the non-mutated EMCV 3C protease. The retention of the ability of the EMCV 3C[K(1-12)R] protease to cleave the leader (L) protein from the EMCV polyprotein capsid precursor LVP0 (40) is shown in Fig. 5D. This suggests that the mutations do not have a major effect on the higher order structure of the protein. These results demonstrate that more than one lysine in the EMCV 3C protease can be used as the site for the initial attachment of Ub to the protein in reticulocyte lysate.


View larger version (41K):
[in this window]
[in a new window]
 
Fig. 5.   Evaluation of the ability of lysine to arginine mutants of the EMCV 3C protease to serve as substrates for the reticulocyte Ub-mediated proteolytic system. A, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized EMCV 3C protease proteins with multiple lysine to arginine substitutions were incubated in the presence of MeUb. Lane 1, non-mutated EMCV 3C protease, 0 min; lane 2, non-mutated EMCV 3C protease, 60 min; lane 3, EMCV 3C[K(1-5)R] protease, 0 min; lane 4, EMCV 3C[K(1-5)R] protease, 60 min; lane 5, EMCV 3C[K(8-12)R] protease, 0 min; lane 6, EMCV 3C[K(8-12)R] protease, 60 min; lane 7, EMCV 3C[K(6-12)R] protease, 0 min; lane 8, EMCV 3C[K(6-12)R] protease, 60 min; lane 9, EMCV 3C[K(1-12)R] protease, 0 min; and lane 10, EMCV 3C[K(1-12)R] protease, 60 min. * indicates the location of mono-Ub conjugates. B, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized non-mutated and mutated EMCV 3C protease proteins were incubated in the presence of added Ub. Lanes 1-3, non-mutated EMCV 3C protease; lanes 4-6, EMCV 3C[K(1-5)R] protease; lanes 7-9, EMCV 3C[K(8-12)R] protease; lanes 10-12, EMCV 3C[K(6-12)R] protease; lanes 12-15, EMCV 3C[K(1-12)R] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1, 4, 7, 10, and 13), 30 min (lanes 2, 5, 8, 11, and 14), and 180 min (lanes 3, 6, 9, 12, and 15). The smaller, minor product that migrates below the 22-kDa 3C protease proteins is the result of translation initiation at a methionine codon in a Kozak consensus context (35), located a short distance downstream of the primary initiation site. This is easily visible here because of the size of the gels utilized in the analysis. C, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized EMCV 3C and 3C[K(1-12)R] protease proteins were incubated in the absence or presence of lactacystin and added Ub. Lanes 1-5, non-mutated EMCV 3C protease; lanes 6-10, EMCV 3C[K(1-12)R] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1 and 6), 10 min (lanes 2 and 7), 30 min (lanes 3 and 8), 60 min (lanes 4 and 9), and 120 min (lanes 5 and 10). D, autoradiograph of the SDS-PAGE analysis of reaction mixtures containing in vitro synthesized labeled EMCV LVP0 polyprotein capsid precursor and unlabeled EMCV 3C or 3C[K(1-12)R] protease proteins. Lanes 1-4, LVP0 polyprotein only; lanes 5-7, LVP0 polyprotein plus non-mutated EMCV 3C protease; lanes 8-10, LVP0 polyprotein plus EMCV 3C[K(1-12)R] protease. Aliquots were removed from the reaction mixtures at 0 min (lane 1), 10 min (lanes 2, 5, and 8), 30 min (lanes 3, 6, and 9), and 60 min (lanes 4, 7, and 10). The locations of the LVP0 polyprotein precursor and the product VP0 diprotein and leader (L) protein are indicated.

Confirmation That the HAV 3C Protease Also Contains a Destruction Signal-- As discussed above, we predicted that the HAV 3C protease contains a destruction signal sequence, presumably the 10-amino acid sequence that is aligned with the EMCV 3C protease signal sequence in Fig. 2, i.e. LGVKDDWLLV. This prediction was tested by evaluating the ability of HAV 3C protease with mutations in the LGV and LLV triplets to serve as substrates for conjugation with Ub. The results of incubating the in vitro synthesized proteins containing either L32A plus V34A or L39A, L40A, and V41A mutations in reticulocyte lysate in the presence of MeUb is shown in Fig. 6A. The ability of both mutants to become incorporated into mono-Ub conjugates was sharply attenuated. The rates at which both mutated proteins are degraded was also reduced (Fig. 6B). These results confirm that the HAV 3C protease LGVKDDWLLV sequence comprises at least part of a destruction signal sequence.


View larger version (73K):
[in this window]
[in a new window]
 
Fig. 6.   Evaluation of the ability of the HAV 3C[LGV(32-34)AGA]- and 3C[LVV(39-41)AAA] protein mutants to serve as substrates for the reticulocyte Ub-mediated proteolytic system. A, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized non-mutated and mutated HAV 3C protease proteins were incubated in the presence of MeUb. Lanes 1-3, non-mutated HAV 3C protease; lanes 4-6, HAV 3C[LGV(32-34)AGA] protease; lanes 7-9, HAV 3C[LVV(39-41)AAA] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1, 4 and 7), 15 min (lanes 2, 5 and 8), and 60 min (lanes 3, 6 and 9). * indicates the location of mono-Ub conjugates. B, autoradiograph of the SDS-PAGE analysis of aliquots of reaction mixtures in which in vitro synthesized non-mutated and mutated HAV 3C protease proteins were incubated in the presence of added Ub. Lanes 1-4, non-mutated HAV 3C protease; lanes 5-8, HAV 3C[LGV(32-34)AGA] protease; lanes 9-12, HAV 3C[LVV(39-41)AAA] protease. Aliquots were removed from the reaction mixtures at 0 min (lanes 1, 5, and 9,), 30 min (lanes 2, 6 and 10), 90 min (lanes 3, 7, and 11), and 180 min (lanes 4, 8, and 12).

Partial Purification and Identification of an E3 Ub-Protein Ligase That Recognizes the EMCV 3C Protease Destruction Signal-- By having identified a sequence in the EMCV 3C protease required for the attachment of Ub to occur, we attempted to at least partially purify the E3 Ub-protein ligase that interacts with this signal. Reconstitution experiments with rabbit reticulocyte lysate fraction II (48) and a crude rabbit Ubc5 E2 preparation revealed that Ubc5 can support the ubiquitination of the EMCV 3C protease, presumably by functioning in a pathway with the E1-activating enzyme and an E3 present in fraction II. A screening of (NH4)2SO4 precipitate fractions revealed that this E3 activity resides in the 0-30% (NH4)2SO4 fraction. This material was used as a starting point for a small scale purification of the E3 activity. The progress of the purification was monitored using a reconstitution mixture composed of purified wild type EMCV 3C protease, Ub, purified rabbit E1, human UbcH5 purified from expressing E. coli cells (47), and E3 ligase-containing fractions.

The details of the purification scheme are described under "Experimental Procedures." The 0-30% (NH4)2SO4 precipitate material was further fractionated by anion exchange chromatography on a column of Q-Sepharose, size exclusion chromatography on a column of Sephadex S-200, and hydrophobic interaction chromatography on a column of methyl-HIC resin. The composition of the most active fraction recovered from the methyl-HIC resin is shown in Fig. 7A. Six major proteins are visible, along with several minor ones. A demonstration of the catalytic activity of this E3 fraction is shown in the Western blot, probed with anti-3C protease antibodies, in Fig. 7B, lanes 1-4. The formation of mono- and poly-Ub conjugates of the EMCV 3C protease is apparent, and the synthesis of these products requires the E3 preparation.


View larger version (28K):
[in this window]
[in a new window]
 
Fig. 7.   E3 Ub-protein ligase activities that catalyze the ubiquitination of the EMCV 3C protease. A, SDS-PAGE and Coomassie stain analysis of a partially purified E3 preparation derived from rabbit reticulocyte fraction II. Lane 1, molecular mass standards; lane 2, 15 µg of E3 preparation eluted from a methyl-HIC column. B, demonstration of the activity of the partially purified E3 in catalyzing the synthesis of Ub-3C protease conjugates. All reaction mixtures were incubated for 60 min and included in addition to 9 µM EMCV 3C protease and Ub: lane 1, nothing; lane 2, E1 and UbcH5; lane 3, E1, and the E3 preparation; lane 4, E1, UbcH5, and the E3 preparation; lane 5, E1 and E2-14K; lane 6, E1, E2-14K, and the E3 preparation. C, demonstration of the activity of affinity purified E3alpha in catalyzing the synthesis of Ub-3C protease conjugates. The reaction mixtures were incubated for 60 min and included in addition to 9 µM EMCV 3C protease and Ub: lane 1, E1 and E2-14K; lane 2, E1, E2-14K, and E3alpha . The results shown in B and C were generated using Western blotting and development with alkaline phosphatase-conjugated secondary antibody.

Several other E2 enzymes were tested for their ability to function with the E3 preparation, in place of UbcH5. As Fig. 7B, lane 6, shows, E2-14K from rabbit reticulocytes supported the formation of Ub-EMCV 3C protease conjugates in the presence of the E3 preparation. These results were something of a surprise, since E2-14K appears to work exclusively with E3alpha (57). The E3 preparation contains a protein that migrates in SDS-PAGE gels with a mass consistent with that of a subunit of E3alpha , which was about 180 kDa (Ref. 28; Fig. 7A). These observations support the notion that the preparation contains E3alpha , which is capable of recognizing the EMCV 3C protease as a substrate for ubiquitination. In order to confirm this, affinity purified human E3alpha was tested in the reconstituted system. This E3, in combination with E2-14K, was indeed found to catalyze the synthesis of Ub-EMCV 3C protease conjugates (Fig. 7C).

These results demonstrate that the Ub-protein ligase E3alpha recognizes the EMCV 3C protease as a substrate for ubiquitination. A second, Ubc5-dependent E3 protein also appears to be capable of participating in the synthesis of Ub-3C protease conjugates. The two E3 activities apparently co-precipitated in the same (NH4)2SO4 fraction and at least partially co-eluted from each of the chromatography matrices employed in the purification procedure. In order to determine directly whether the recognition of the EMCV 3C protease by one, or both, of these E3 proteins requires the identified destruction signal, experiments were carried out using a purified 3C protease with a mutated destruction signal sequence. The EMCV 3C[LVV(41-43)AAA] protease, which retains catalytic activity but is a poor substrate for conjugation with Ub (Fig. 3), was expressed in E. coli cells and purified. When wild type EMCV 3C protease or the 3C[LVV(41-43)AAA] protease was incubated in the reconstituted system with MeUb, in the presence of either affinity purified E3alpha plus E2-14K or the partially purified E3 preparation plus UbcH5, the results shown by the Western blots in Fig. 8 were obtained. E3alpha catalyzed the ubiquitination of the wild type protease much more rapidly than it did the 3C protease with the mutation in the destruction signal (Fig. 8A). This result provides a direct link between the integrity of the destruction signal sequence and the ability of E3alpha to catalyze the ubiquitination of the EMCV 3C. The Ubc5-dependent E3, however, catalyzed the attachment of Ub to both the wild type and the mutated proteins at similar rates (Fig. 8B). This E3 does not, therefore, utilize the identified destruction signal or at least not the C-terminal portion of the signal sequence.


View larger version (72K):
[in this window]
[in a new window]
 
Fig. 8.   Evaluation of the ability of the Ub-protein ligase preparations to catalyze the ubiquitination of the EMCV 3C protease containing a mutated destruction signal sequence. A, demonstration of the activity of purified E3alpha in catalyzing the synthesis of Ub-3C protease conjugates. Lanes 1-4 show the analysis of reaction mixtures containing 1 µM 3C protease, MeUb, E1, E2-14K, and E3alpha . Lanes 5-8 show the analysis of reaction mixtures containing 1 µM 3C[LVV(41-43)AAA] protease, MeUb, E1, E2-14K, and E3alpha . Aliquots were removed at 0 min (lanes 1 and 5), 10 min (lanes 2 and 6), 20 min (lanes 3 and 7), and 60 min (lanes 4 and 8). B, demonstration of the activity of the partially purified Ubc5-dependent E3 in catalyzing the synthesis of Ub-3C protease conjugates. Lanes 1-4 show the analysis of reaction mixtures containing 1 µM 3C protease, MeUb, E1, UbcH5, and the E3 preparation. Lanes 5-8 show the analysis of reaction mixtures containing 1 µM 3C[LVV(41-43)AAA] protease, MeUb, E1, UbcH5, and the E3 preparation. Aliquots were removed at 0 min (lanes 1 and 5), 10 min (lanes 2 and 6), 20 min (lanes 3 and 7), and 60 min (lanes 4 and 8). The results shown were generated using Western blotting and development with ECL.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Although considerable understanding of how the Ub-mediated proteolytic system functions to selectively degrade proteins has been gained in recent years, the mechanism by which proteins are recognized as substrates for this system has largely remained undefined. We have identified a previously unknown protein destruction signal in the rapidly degraded EMCV 3C protease, a protein that is crucial for viral replication. The sequence LLVRGRTLVV, located at positions 34-43, has been demonstrated here to contribute, at least in vitro, to the recognition of the EMCV 3C protease for ubiquitination and to be necessary for the rapid destruction of the protein. Evidence was also obtained which suggests that the HAV 3C protease contains a destruction signal sequence (LGVKDDWLLV) in a location homologous with that of the EMCV 3C protease.

An examination of the crystal structures of the picornavirus 3C proteases that have been determined to date reveal that they are conserved (53-55). The putative HAV 3C protease destruction signal sequence coincides with segments of two antiparallel beta -sheet strands connected by a surface-exposed turn. The internal sequence changes made in the poliovirus 3C protease, which converted it to a substrate for the Ub system, are located in an identically placed structure. It is likely that the EMCV 3C protease signal sequence is placed in a similar location as well. This would mean that the central four, mostly hydrophilic, amino acids in the EMCV 3C protease signal exist in a surface-exposed loop which connects two strands of an antiparallel beta -sheet. The leucine/valine-rich hydrophobic triplets would occupy the strand portions of the signal. The comparable strand sequences in the HAV and poliovirus 3C protease strand segments are not exposed on the surfaces of the proteins (53, 55), but it is possible to imagine them becoming accessible though a partial unfolding of the protein structure. It may be that the secondary structure of the signal region in the native protein contributes to its identity as a recognition element for the Ub-mediated proteolytic system. That the EMCV 3C protease signal sequence linked to the N terminus of the poliovirus 3C protease was observed to bring about the ubiquitination of the poliovirus protein may, however, indicate that the strand-turn-strand motif is not an absolute requirement for the signal to function. The folding of the signal sequence in this context may be different than that which occurs in the internal location in the native EMCV 3C protease.

An analysis of the effects of mutations in the EMCV 3C protease signal sequence indicates that the signal can tolerate considerable sequence variability and remain functional, although certain definable characteristics appear to contribute to its ability to function. The data, along with the comparisons between the EMCV, HAV, and poliovirus 3C protease sequences, suggest a leucine must be present in the first position of the signal sequence and that the three positions on either end of the signal sequence must contain a high density of amino acids with branched aliphatic R groups (leucines and valines). The absence of these residues in the C-terminal triplet of the poliovirus 3C protease sequence which aligns with the EMCV 3C and putative HAV 3C protease destruction signals was shown to be a major contributing factor to the stability of the poliovirus protein. These results are also consistent with observations made in studies with artificial substrates (58, 59), which indicate that short sequences of bulky hydrophobic amino acids can cause proteins to be recognized for Ub-mediated degradation. Given the strand-turn-strand structure in which the signal appears to reside, the four amino acids that occupy the center of the signal may also comprise an another important feature, since these residues would contribute to the formation of the hydrophilic loop. Although the data obtained shows that sequence in this region can be highly variable, any combination of polar amino acids does not support the generation of a functional destruction signal. Other experiments with EMCV 3C protease proteins containing lysine to arginine substitutions revealed that the location of the destruction signal does not restrict the initial attachment of Ub to a specific lysine residue. The absence of unique ubiquitination sites has been reported to exist for other substrates of the Ub-mediated proteolytic system (19, 60, 61).

Two E3 Ub-protein ligases were shown to be involved in the ubiquitination of the EMCV 3C protease. One of these was identified as E3alpha , and this was demonstrated by reconstitution experiments to require the identified destruction signal sequence to participate in the attachment of Ub to the 3C protease protein. Although the most straightforward interpretation of these results is that E3alpha binds to the EMCV 3C protease signal during initial substrate recognition, it is possible that a necessary interaction between E3alpha and the signal occurs subsequently to this step. Preliminary experiments have demonstrated that E3alpha can also participate in the ubiquitination of the HAV 3C protease,3 presumably by interacting with the destruction signal identified in that protein. E3alpha has been thought to recognize only proteins with certain N-terminal amino acids (29, 30). Its yeast homologue, Ubr1, has, however, recently been found to participate in the ubiquitination of yeast proteins Galpha and Cup9, both of which have internally located destruction signals (18, 23, 25). A search of the reported signal regions for both of these proteins did not reveal the presence of a sequence that mimics the EMCV or HAV 3C protease destruction signal sequences. This may indicate that mammalian E3alpha and yeast Ubr1 recognize dissimilar internally located signal elements or that these E3 proteins are capable of interacting with more than one type of internal signal feature.

The second E3 shown to be capable of catalyzing the ubiquitination of the EMCV 3C protease functions with the E2 Ubc5. This may, therefore, be an E3 that belongs to the hect family of Ub-protein ligases (32). This E3 was found not to require the LLVRGRTLVV destruction signal sequence to recognize the 3C protease. It is unclear what structural features are recognized by the Ubc5-dependent E3. The fact that no ubiquitination was observed to occur in reticulocyte lysate with proteins containing only the C-terminal 113 amino acids or with N-terminal deletion mutants lacking the first 46 amino acids suggests the N-terminal region contains a recognition element necessary for this E3 to interact with the 3C protease. It appears that, in reticulocyte lysate, at least, the Ubc5-dependent E3 is responsible for a much smaller fraction of the Ub-3C protease conjugate synthesis than is E3alpha . This is indicated by the sharply attenuated rate of ubiquitination and degradation that was observed for some of the EMCV 3C protease proteins containing mutations in the E3alpha destruction signal sequence.

It is likely that the protein destruction signal identified here also exists in one or more cellular proteins, since the ability of the ubiquitin system to recognize this signal would be expected to have evolved to meet the needs of cells not infected with picornaviruses. Because of the apparent degeneracy of the signal sequence, and because the secondary structure of the signal region may contribute to the efficiency with which it functions, meaningful searches of protein data bases for other examples of the signal are difficult. A search of the SWISS-PROT data base, however, revealed the existence of at least 17 eukaryotic cellular and 5 (in addition to the EMCV and HAV 3C proteases) mammalian viral proteins with candidate destruction signal sequences. These proteins all contain the sequence Leu-(Gly, Leu, or Val)-(Leu or Val)-X4-(Leu or Val)3, where X represents amino acids frequently found in reverse turns.

It remains to be seen if the identified destruction signal functions in vivo the same way it functions in vitro. Similarities between the kinetics of the EMCV 3C protease degradation in vitro and in vivo (35, 39, 40) suggest similar mechanisms of destruction occur in both systems. Detailed studies of the behavior of destruction signal mutants of the 3C protein in vivo will be required to answer this question. It is also not yet clear what function, if any, the rapid degradation of the EMCV and HAV 3C proteases serves during the replication of these viruses. In the case of EMCV, at least, the amount of 3C protease present reaches a maximum 2-3 h into the infectious cycle and then rapidly declines to near undetectable levels by the time the cells lyse (39). It may be that the presence of 3C protease activity during the later phases of the infectious cycle is detrimental to virus reproduction. It is also unclear why the 3C protease of poliovirus has evolved to be relatively stable. The ability to now generate catalytically active, relatively stable versions of the EMCV and HAV 3C proteases will allow future studies into whether the rapid and selective degradation of these proteins is biologically important.

    ACKNOWLEDGEMENTS

We are deeply indebted to Cecile Pickart and Art Haas for valuable discussions, advice, and the provision of enzyme preparations.

    FOOTNOTES

* This work was supported by National Science Foundation RUI Award MCB-9505810 and by a Henry Dreyfus Teacher-Scholar Award.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed. Tel.: 207-786-6293; Fax: 207-786-8336; E-mail: tlawson{at}bates.edu.

2 L. Mastrandrea and C. Pickart, personal communication.

3 T. G. Lawson, D. L. Gronros, P. E. Evans, M. C. Bastien, K. M. Michalewich, J. K. Clark, J. H. Edmonds, K. H. Graber, J. A. Werner, B. A. Lurvey, and J. M. Cate, unpublished data.

    ABBREVIATIONS

The abbreviations used are: Ub, ubiquitin; DTT, dithiothreitol; EMCV, encephalomyocarditis virus; HAV, hepatitis A virus; HIC, hydrophobic interaction chromatography; MeUb, methylated ubiquitin; PCR, polymerase chain reaction; PAGE, polyacrylamide gel electrophoresis; E1, ubiquitin-activating enzyme; E2, ubiquitin carrier protein; E3, ubiquitin-protein isopeptide ligase.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
  1. Varshavsky, A. (1997) Trends Biochem. Sci. 22, 383-387[CrossRef][Medline] [Order article via Infotrieve]
  2. Scheffner, M., Smith, S., and Jentsch, S. (1998) in Ubiquitin and the Biology of the Cell (Peters, J.-M., Harris, J. R., and Finley, D., eds), pp. 65-98, Plenum Publishing Corp., New York
  3. Glotzer, M., Murray, A. W., and Kirschner, M. W. (1991) Nature 349, 132-138[CrossRef][Medline] [Order article via Infotrieve]
  4. Klotzbúcher, A., Stewart, E., Harrison, D., and Hunt, T. (1996) EMBO J. 15, 3053-3064[Abstract]
  5. Kaplon, T., and Jacquet, M. (1995) J. Biol. Chem. 270, 20742-20747[Abstract/Free Full Text]
  6. Funabiki, H., Yamano, H., Nagao, K., Tanaka, H., Yasuda, H., Hunt, T., and Yanagida, M. (1997) EMBO J. 16, 5977-5987[Abstract/Free Full Text]
  7. Rogers, S., Wells, R., and Rechsteiner, M. (1986) Science 234, 364-368[Medline] [Order article via Infotrieve]
  8. Kornitzer, D., Raboy, B., Kulka, R. G., and Fink, G. R. (1994) EMBO J. 13, 6021-6030[Abstract]
  9. Salama, S. R., Hendricks, K. B., and Thorner, J. (1994) Mol. Cell. Biol. 14, 7953-7966[Abstract]
  10. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. (1995) Science 267, 1485-1488[Medline] [Order article via Infotrieve]
  11. Tsurumi, C., Ishida, N., Tamura, T., Kakizuka, A., Nishida, E., Okumura, E., Kishimoto, T., Inagaki, M., Okazaki, K., Sagata, N., Ichihara, A., and Tanaka, K. (1995) Mol. Cell. Biol. 15, 5682-5687[Abstract]
  12. Yaglom, J., Linskens, M. H., Sadis, S., Rubin, D. M., Futcher, B., and Finley, D. (1995) Mol. Cell. Biol. 15, 731-741[Abstract]
  13. Krappmann, D., Wulczyn, F. G., and Scheidereit, C. (1996) EMBO J. 15, 6716-6726[Abstract]
  14. Roth, A. F., Sullivan, D. M., and Davis, N. G. (1998) J. Cell Biol. 142, 949-961[Abstract/Free Full Text]
  15. Bachmair, A., Finley, D., and Varshavsky, A. (1986) Science 234, 179-186[Medline] [Order article via Infotrieve]
  16. Johnson, S., Gonda, D. K., and Varshavsky, A. (1990) Nature 346, 287-291[CrossRef][Medline] [Order article via Infotrieve]
  17. Nishizawa, M., Furuno, N., Okazaki, K., Tanaka, H., Ogawa, Y., and Sagata, N. (1993) EMBO J. 12, 4021-4027[Abstract]
  18. Madura, K., and Varshavsky, A. (1994) Science 265, 1454-1458[Medline] [Order article via Infotrieve]
  19. Treier, M., Staszewski, L., and Bohmann, D. (1994) Cell 78, 787-798[Medline] [Order article via Infotrieve]
  20. Hateborer, G., Kerkhoven, R. M., Shvarts, A., Bernards, R., and Beijersbergen, R. L. (1996) Genes Dev. 10, 2969-2970
  21. Huibregste, J. M., Yang, J. C., and Beaudenon, S. L. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 3656-3661[Abstract/Free Full Text]
  22. Nielsen, K. H., Papageorge, A. G., Vass, W. C., Willumsen, B. M., and Lowy, D. R. (1997) Mol. Cell. Biol. 17, 7132-7138[Abstract]
  23. Byrd, C., Turner, G. C., and Varshavsky, A. (1998) EMBO J. 17, 269-277[Abstract/Free Full Text]
  24. Johnson, P. R., Swanson, R., Rakhillna, L., and Hochstrasser, M. (1998) Cell 94, 217-227[Medline] [Order article via Infotrieve]
  25. Schauber, C., Chen, L., Tongaonkar, P., Vega, I., and Madura, K. (1998) Genes Cells 3, 307-319[Abstract/Free Full Text]
  26. Schwarz, S. E., Rosa, J. L., and Scheffner, M. (1998) J. Biol. Chem. 273, 12148-12154[Abstract/Free Full Text]
  27. Bai, C., Hofmann, K., Goeble, M., Harper, J. W., and Elledge, S. J. (1996) Cell 86, 263-274[Medline] [Order article via Infotrieve]
  28. Hershko, A., Heller, H., Eytan, E., and Reiss, Y. (1986) J. Biol. Chem. 261, 11992-11999[Abstract/Free Full Text]
  29. Reiss, Y., Heller, H., and Hershko, A. (1989) J. Biol. Chem. 264, 10378-10383[Abstract/Free Full Text]
  30. Bartel, B., Wünning, I., and Varshavsky, A. (1990) EMBO J. 9, 3179-3189[Abstract]
  31. Kwon, Y. T., Reiss, Y., Fried, V. A., Hershko, A., Yoon, J. K., Gonda, D. K., Sangan, P., Copeland, N. G., Jenkins, N. A., and Varshavsky, A. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 7898-7903[Abstract/Free Full Text]
  32. Huibregste, J. M., Scheffner, M., Beaudenon, S., and Howley, P (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 2563-2567[Abstract]
  33. King, R. W., Peters, J.-M., Tugendreich, S., Rolfe, M., Hieter, P., and Kirschner, M. W. (1995) Cell 81, 279-288[Medline] [Order article via Infotrieve]
  34. Sudakin, V., Ganoth, D., Dahan, A., Heller, H., Hershko, J., Luca, F. C., Ruderman, J. V., and Hershko, A. (1995) Mol. Biol. Cell 6, 185-198[Abstract]
  35. Lawson, T. G., Gronros, D. L., Werner, J. A., Wey, A. C., DiGeorge, A. M., Lockhart, J. L., Wilson, J. W., and Wintrode, P. L. (1994) J. Biol. Chem. 269, 28429-28435[Abstract/Free Full Text]
  36. Gladding, R. L., Haas, A. L., Gronros, D. L., and Lawson, T. G. (1997) Biochem. Biophys. Res. Commun. 238, 119-125[CrossRef][Medline] [Order article via Infotrieve]
  37. Kräusslich, H.-G., Nicklin, M. J. H., Lee, C.-K., and Wimmer, E. (1988) Biochemie (Paris) 70, 119-130
  38. Palmenberg, A. C. (1990) Annu. Rev. Microbiol. 44, 603-623[CrossRef][Medline] [Order article via Infotrieve]
  39. Lawson, T. G., Smith, L. L., Palmenberg, A. C., and Thach, R. E. (1989) J. Virol. 63, 5013-5022[Medline] [Order article via Infotrieve]
  40. Oberst, M. D., Gollan, T. J., Gupta, M., Peura, S. R., Zydlewski, J. D., Sudarsanan, P., and Lawson, T. G. (1993) Virology 193, 28-40[CrossRef][Medline] [Order article via Infotrieve]
  41. Gauss-Müller, V., Jurgensen, D., and Deutzmann, R. (1991) Virology 182, 861-864[Medline] [Order article via Infotrieve]
  42. Ypma-Wong, M. F., and Semler, B. L. (1987) J. Virol. 61, 3181-3189[Medline] [Order article via Infotrieve]
  43. Teser, M., Pak, I., Jia, X.-Y., Richards, O. C., Summers, D. F., and Ehrenfeld, O. C. (1994) Virology 198, 524-533[CrossRef][Medline] [Order article via Infotrieve]
  44. Studier, F. W., Rosenberg, A. H., Dunn, J. J., and Dubendorff, J. W. (1990) Methods Enzymol. 185, 60-89[Medline] [Order article via Infotrieve]
  45. Hershko, A., and Heller, H. (1985) Biochem. Biophys. Res. Commun. 128, 1079-1086[Medline] [Order article via Infotrieve]
  46. Mayer, A. N., and Wilkinson, K. D. (1989) Biochemistry 28, 166-172[Medline] [Order article via Infotrieve]
  47. Scheffner, M., Huibregste, J. M., and Howley, P. M. (1994) Proc. Natl. Acad. Sci. U. S. A. 91, 8797-8801[Abstract]
  48. Hershko, A., Heller, H., Elias, S., and Ciechanover, A. (1983) J. Biol. Chem. 258, 8206-8214[Abstract/Free Full Text]
  49. Racaniello, V. R., and Baltimore, D. (1981) Proc. Natl. Acad. Sci. U. S. A. 78, 4887-4891[Abstract]
  50. Palmenberg, A. C., Kirby, E. M., Janda, M. R., Drake, N. L., Duke, G. M., Potratz, K. F., and Collett, M. S. (1984) Nucleic Acids Res. 12, 2969-2985[Abstract]
  51. Paul, A. V., Tada, H., von der Helm, K., Wissel, T., Kiehn, R., Wimmer, E., and Deinhardt, F. (1987) Virus Res. 8, 153-171[CrossRef][Medline] [Order article via Infotrieve]
  52. Ryan, M. D., and Flint, M. (1997) J. Gen. Virol. 78, 699-723[Free Full Text]
  53. Allaire, M., Chernaia, M. M., Malcolm, B. A., and James, M. N. G. (1994) Nature 369, 72-76[CrossRef][Medline] [Order article via Infotrieve]
  54. Matthews, D. A., Smith, W. W., Ferre, R. A., Condon, B., Budahazi, G., Sisson, W., Villafranca, J. E., Janson, C. A., McElroy, H. E., Gribskov, C. L., and Worland, S. (1994) Cell 77, 761-771[Medline] [Order article via Infotrieve]
  55. Mosimann, S. C., Cherney, M. M., Sia, S., Plotch, S., and James, M. N. G. (1997) J. Mol. Biol. 273, 1032-1047[CrossRef][Medline] [Order article via Infotrieve]
  56. Fenteany, G., Standaert, R. F., Lane, W. S., Choi, C. S., Corey, E. J., and Schreiber, S. L. (1995) Science 268, 726-731[Medline] [Order article via Infotrieve]
  57. Sung, P., Berleth, E., Pickart, C., Prakash, S., and Prakash, L. (1991) EMBO J. 10, 2187-2193[Abstract]
  58. Sadis, S., Atienza, C., and Finley, D. (1995) Mol. Cell. Biol. 15, 4086-4094[Abstract]
  59. Gilon, T., Chomsky, O., and Kulka, R. G. (1998) EMBO J. 17, 2759-2766[Abstract/Free Full Text]
  60. King, R. W., Glotzer, M., and Kirschner, M. W. (1996) Mol. Biol. Cell 7, 1343-1357[Abstract]
  61. Sokolik, C. W., and Cohen, R. E. (1991) J. Biol. Chem. 266, 9100-9107[Abstract/Free Full Text]


Copyright © 1999 by The American Society for Biochemistry and Molecular Biology, Inc.